Početna › Leukemija › Ohio › Columbus
Kliničke studije za Leukemija u gradu Columbus, OH
12 studija za Leukemija traži sudionike na lokacijama u gradu Columbus i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
U tijeku regrutacijaFaza 3
- Quetzal Site 8, Columbus
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
U tijeku regrutacijaFaza 1/2
- Ohio State University, Columbus
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
U tijeku regrutacijaFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
U tijeku regrutacijaFaza 3
- Ohio State University, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
U tijeku regrutacijaFaza 1/2
- The Ohio State University Wexner Medical Center, Columbus
Hairy Cell Leukemia Patient Data Registry
U tijeku regrutacijaOpažajna studija
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
U tijeku regrutacijaFaza 1/2
- Dren Investigational Site, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
U tijeku regrutacijaFaza 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
U tijeku regrutacijaFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
U tijeku regrutacijaFaza 1
- The James Cancer Hospital and Solove Research Institute, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Columbus
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
U tijeku regrutacijaFaza 1
- The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
Studije za Leukemija u drugim gradovima
- Houston, TX28 studija
- Boston, MA25 studija
- New York City, NY19 studija
- Los Angeles, CA16 studija
- Chicago, IL16 studija
- Durham, NC13 studija
- Baldwin Park, CA12 studija
- Nashville, TN12 studija
- Philadelphia, PA12 studija
- Milwaukee, WI11 studija
- Atlanta, GA11 studija
- Seattle, WA11 studija
Ostale studije u gradu Columbus
- Nemikrocelularni karcinom pluća56 studija
- Rak dojke39 studija
- Rak jajnika39 studija
- Rak (sve vrste)38 studija
- Rak pluća37 studija
- Akutna mijeloična leukemija35 studija
- Kronična limfocitna leukemija28 studija
- Metastatski karcinom27 studija
- Rak endometrija25 studija
- Kolorektalni rak24 studija
- Rak prostate24 studija
- Multipli mijelom24 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.